Overview

A good prognosis: Revenue is expected to grow in the current year as visits to GPs increase

IBISWorld’s Pathology and Diagnostic Imaging Services in New Zealand market research report can be used to help you: understand market size and growth potential; major companies; draft business plans and pitch books; and conduct benchmarking and SWOT analysis. Our industry analysis highlights macro industry trends in the overall sector and micro trends faced by companies that do business in the industry. The industry report also provides key industry statistics and 5-year forecasts to anticipate future industry prospects so you can decide with confidence.

REPORT SNAPSHOT

Industry Analysis & Industry Trends

The Pathology and Diagnostic Imaging Services industry has benefited from consistent underlying demand over the past five years. Diagnostic imaging and pathology services play a critical role in providing health practitioners with information that supports medical diagnoses and treatment. Steady growth in the population aged 50 and older supported industry growth from 2014-15 onwards. As people get older, the prevalence of age-related illness and disease tends to increase. This typically causes the number of doctor referrals to diagnostic imaging and pathology service centres to increase, boosting industry demand. However, industry revenue is expected to decrease by an annualised 0.8% over the five years through 2017-18, to total $792.9 million...

shopping_cartBUY NOW TO READ MORE

What is the Pathology and Diagnostic Imaging Services in New Zealand industry?

Market share concentration in the Pathology and Diagnostic Imaging Services industry is moderate. The four largest players are expected to account for approximately 45% of industry revenue in 2017-18. The industry's largest player, APHG NZ Investments Limited, holds a sizeable share of the industry through its portfolio brands including Labtests, Southern Community Laboratories and Northland Pathology. Industry market share concentration increased when APHG NZ acquired Abano Healthcare Group's pathology arm, Aotea Pathology, following its successful tender of several District Health Board contracts across the North Island. The...

shopping_cartBUY NOW TO READ MORE

Look under the hood?

Download a FREE sample report

Click here to read our

New Zealand Special Report

Products & Brands

Major products in this industry
Pathology services
Ultrasounds
Other diagnostic imaging
Examples of brands in this Industry
Labtests
Northland Pathology
Southern Community Laboratories

Table of Contents

About this Industry

Industry Definition
Main Activities
Similar Industries
Additional Resources

Industry at a Glance

Industry Performance

Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle

Products & Markets

Supply Chain
Products & Services
Major Markets

Globalisation & Trade

Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry

Major Companies

Operating Conditions

Capital Intensity

Key Statistics

Industry Data
Annual Change
Key Ratios

Jargon & Glossary

Contact Us

Want to speak to a representative? Call us.

clear